Thursday, 25 April 2024
Five Prime Therapeutics Inc.
-
Overlay
-
Indicators
-
Settings
-
Period
06:03 | 13/2/18
Post Analyst
As regular trading ended, Five Prime Therapeutics, Inc. (FPRX) stock brought in a -$0.11 drop to $18.27. The day started at a price of $18.62 but then traded as high as $18.91 before giving part of the gains back.
more»
10:10 | 9/2/18
GlobeNewswire
Five Prime Therapeutics, Inc. discovers and develops innovative therapeutics to improve the lives of patients with serious diseases.
more»
11:30 | 7/2/18
Equities.com
Five Prime Therapeutics Inc. (FPRX) traded on unusually high volume on Feb. 06, as the stock gained 4.45% to close at $19.24.
more»
The results here are provided for general informational purposes, as a convenience to the readers. The materials are not a substitute for obtaining professional advice from a qualified person, firm or corporation.
more»
11:30 | 3/2/18
StockNewsTimes
Five Prime Therapeutics logo Shares of Five Prime Therapeutics Inc (NASDAQ:FPRX) have received an average rating of “Buy” from the ten research firms that are covering the company, Marketbeat Ratings reports.
more»
11:30 | 31/1/18
Equities.com
Five Prime Therapeutics Inc. (FPRX) had a rough trading day for Tuesday January 30 as shares tumbled 5.3%, or a loss of $-1.17 per share, to close at $20.89.
more»
10:00 | 30/1/18
GlobeNewswire
SOUTH SAN FRANCISCO, Calif., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) announced today the closing of its upsized public offering of 5,897,435 shares of its common stock, which includes 769,230 shares sold upon the ...
more»
10:11 | 26/1/18
GlobeNewswire
SOUTH SAN FRANCISCO, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today announced that a development milestone ...
more»
01:56 | 26/1/18
StreetInsider.com
Five Prime Therapeutics, Inc. (Nasdaq: FPRX), announced today the pricing of an underwritten public offering of 5,128,205 shares of its common stock at a price to the public of $19.50 per share.
more»
11:30 | 25/1/18
Equities.com
Five Prime Therapeutics Inc. (FPRX) had a rough trading day for Wednesday January 24 as shares tumbled 10.21%, or a loss of $-2.29 per share, to close at $20.14.
more»